enoblituzumab
Showing 1 - 5 of 5
Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)
Not yet recruiting
- Prostate Cancer
- Enoblituzumab
- Standard of Care
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 25, 2023
Prostate Cancer Trial in Baltimore (Enoblituzumab)
Active, not recruiting
- Prostate Cancer
- Enoblituzumab
-
Baltimore, MarylandJohns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 16, 2022
Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)
Not yet recruiting
- Cancer
- +4 more
- FT538
- Enoblituzumab
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Jan 24, 2023
Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer Trial in Minneapolis (IP FT516, Enoblituzumab,
Completed
- Ovarian Cancer
- +2 more
- IP FT516
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota, Masonic Cancer Center
Apr 12, 2022
Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma Trial in United States (Enoblituzumab)
Completed
- Neuroblastoma
- +5 more
- Enoblituzumab
-
Palo Alto, California
- +5 more
Feb 4, 2022